RxDoctor Payments Data

Hossam Eldin Mustafa, MD

Clinical Cardiac Electrophysiology · Saginaw, MINPI 1215145420

Payments from drug & device makers

$15,277in general payments, 2019–2025

Across 232 payments — averaging $65.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Boston Scientific$2K
  • Medical Device Business Services, Inc.$2K
  • Biosense Webster, Inc.$667
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$260
  • Novartis$244
  • plus $2K from 33 others

What the payments were for

  • Travel & lodging$8,60156%
  • Food & beverage$6,25841%
  • Education$4183%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,277 in reported general payments places this provider in the 35th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$228,711
Medicare patients
494
Services billed
2,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban402$491,800
MultaqDronedarone Hcl79$99,773
XareltoRivaroxaban43$45,329
EntrestoSacubitril/Valsartan27$41,256
JardianceEmpagliflozin32$37,096
Metoprolol Succinate292$7,030
Amiodarone Hcl139$6,049
Dofetilide35$4,584
Dilt-XrDiltiazem Hcl58$3,779
Diltiazem 24hr Er (Cd)Diltiazem Hcl91$3,514
Diltiazem 24hr Er (La)Diltiazem Hcl25$3,277
Mexiletine Hcl21$3,253
Metoprolol Tartrate198$1,891
Carvedilol99$1,687
Propafenone Hcl21$1,304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$187$491,800402 claims
Sanofi-aventis U.S. LLCMultaq$130$99,77379 claims
Johnson & JohnsonXarelto$175$45,32943 claims
NovartisEntresto$244$41,25627 claims
Boehringer IngelheimJardiance$116$37,09632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

Other clinical cardiac electrophysiology in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →